KALA BIO’s $10.75 Million Private Placement

Wilmer Cutler Pickering Hale and Dorr represented KALA BIO, Inc. in the transaction.KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company, announced it had entered into a…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here